Seliciclib Recruiting Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00999401A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors